TEST INSTRUCTIONS

Read the article. The test for this nursing continuing professional development (NCPD) activity is to be taken online at www.NursingCenter.com/CE/JDNA. Tests can no longer be mailed or faxed. You'll need to create an account (it's free!) and log in to access My Planner before taking online tests. Your planner will keep track of all your Lippincott Professional Development online NCPD activities for you. There's only one correct answer for each question. A passing score for this test is 8 correct answers. If you pass, you can print your certificate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost. For questions, contact Lippincott Professional Development: 1-800-787-8985. Registration deadline is June 5, 2026

PROVIDER ACCREDITATION:

Lippincott Professional Development will award 1.0 contact hour for this nursing continuing professional development activity.

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.0 contact hour. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, West Virginia, New Mexico, South Carolina, and Florida, CE Broker #50-1223. Your certificate is valid in all states.

Payment: The registration fee for this test is $10 for members; $20 for nonmembers.

Learning Outcome: By the conclusion of this activity, a majority of the participants will demonstrate knowledge of the use of telemedicine in dermatology practices by achieving a passing score on the posttest.

Learning Objectives: After completing this continuing professional development activity, the participant will apply knowledge gained to:

1. Identify types of teledermatology (i.e., telederm).

2. Select benefits of using telederm.

3. Discuss challenges to using telederm technology.

4. Select diagnoses that would be appropriate for telederm consults.

What is the more common type of telederm discussed in this article? store-and-forward e-visits via a patient portal live/real-time interactive One of the benefits of the store-and-forward type of telederm is flexibility. HIPAA compliance ensured. simplicity. Telederm and other sources of virtual medicine were widely used in both inpatient and outpatient settings during the COVID-19 pandemic. In general, a value of telederm was greater insurance reimbursement than with in-person visits. improved patient satisfaction. savings in personal protective equipment. The widespread use of telederm during the COVID-19 pandemic exposed many shortages and challenges of the technology, including insufficient storage available for patients’ dermatology photos. minimal or non-existent rural broadband infrastructure. inadequate devices to use for telederm in providers’ offices. An additional challenge was the lack of training of nurses and ancillary staff in uploading and storing the photos. interpreting the data that were collected. capturing adequate and accurate photos. What is one of the factors that the authors report as contributing to poor image quality? not using a resolution that was high enough not including a ruler for measurement not zooming in sufficiently One of the problems encountered with billing third-party providers for telederm services is delayed reimbursement. staff shortages in accounts payable. inappropriate coding. The authors report that patients who particularly benefit from telederm are those with high, technical computer acumen. without reliable transportation. with a long-standing relationship with the provider. The authors note that hospitals and clinics can use telederm to? entirely replace in-person clinic visits. enhance their trainees' education. avoid burdensome privacy challenges. Telederm can be beneficial even when there is concern for a neoplasm. True False